Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation

Current and future directions in mammalian target of rapamycin inhibitors development

(2011) Angelica Fasolo et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Improved Results of a Surgical Resection for the Recurrence of Hepatocellular Carcinoma After Living Donor Liver Transplantation

(2010) Akinobu Taketomi et al.   ANNALS OF SURGICAL ONCOLOGY

Personalized molecular targeted therapy in advanced, recurrent hepatocellular carcinoma after liver transplantation: A proof of principle

(2010) Sherrie Bhoori et al.   JOURNAL OF HEPATOLOGY

mTOR inhibitors and sorafenib for recurrent heptocellular carcinoma after orthotopic liver transplantation

(2010) Oliver Waidmann et al.   JOURNAL OF HEPATOLOGY

Safety and Feasibility of Using Sorafenib in Recurrent Hepatocellular Carcinoma after Orthotopic Liver Transplantation

(2010) Richard Kim et al.   ONCOLOGY

Effect of Different Immunosuppressive Schedules on Recurrence-Free Survival After Liver Transplantation for Hepatocellular Carcinoma

(2010) Marco Vivarelli et al.   TRANSPLANTATION

Management of Hepatocellular Carcinoma Recurrence After Liver Transplantation

(2010) A. Valdivieso et al.   TRANSPLANTATION PROCEEDINGS

Long-term survival after recurrent hepatocellular carcinoma in liver transplant patients: Clinical patterns and outcome variables

(2009) A. Kornberg et al.   EJSO

Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo

(2009) Pippa Newell et al.   JOURNAL OF HEPATOLOGY

Liver Transplantation for Hepatocellular Carcinoma Under Calcineurin Inhibitors

(2008) Marco Vivarelli et al.   ANNALS OF SURGERY

Effect of Rapamycin Alone and in Combination with Sorafenib in an Orthotopic Model of Human Hepatocellular Carcinoma

(2008) Z. Wang et al.   CLINICAL CANCER RESEARCH

Sirolimus inhibits the growth and metastatic progression of hepatocellular carcinoma

(2008) Zheng Wang et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma

(2008) Michael A. Zimmerman et al.   LIVER TRANSPLANTATION

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE